PATENT CLAIM ANALYSIS

Application Number: 16364535
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-07
Patent Classification: ["514", "440000"]

Abstract:
The invention encompasses methods for enhancing the ability of a companion animal to resist and/or overcome viral infections. The methods of the invention include an amount of lipoic acid that is effective in enhancing the antiviral immunity of a companion animal.

Claim (Index 5):
The method of  claim 1 , wherein the one or more genes comprises one or more of CREB-binding protein (CREBBP), Interferon-induced double stranded RNA-activated protein (EIF2AK2), interferon-alpha/beta receptor beta chain precursor (IFNAR2), interferon-gamma receptor beta chain precursor (IFNGR2), interferon regulatory factor 9 (IFR9), Tyrosine protein kinase JAK2 (JAK2), 2-5A-dependent ribonuclease (RNASEL), or combinations thereof.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 99.0
- Lexical Diversity: 1.43333
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12336024', '12319287', '11154210', '16285641', '15589345']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7592771704223722
- 35 USC 102 Novelty (BERT): 0.5240465365078288
- Combined Prediction Score: 0.7357541070309178
- Mean Citation Score: 234.947912
- Max Citation Score: 262.73477
- Similarity Product: 134.35594865902783

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test